RxSight, Inc.
RXST
$13.50
-$0.59-4.19%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -5.77% | 13.88% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -5.77% | 13.88% | |||
| Cost of Revenue | -16.28% | 13.20% | |||
| Gross Profit | -1.59% | 14.15% | |||
| SG&A Expenses | 1.47% | 10.10% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.56% | 9.66% | |||
| Operating Income | -23.71% | 6.48% | |||
| Income Before Tax | -37.90% | 6.31% | |||
| Income Tax Expenses | 50.00% | -7.69% | |||
| Earnings from Continuing Operations | -37.93% | 6.31% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -37.93% | 6.31% | |||
| EBIT | -23.71% | 6.48% | |||
| EBITDA | -22.00% | -0.25% | |||
| EPS Basic | -37.46% | 7.66% | |||
| Normalized Basic EPS | -37.36% | 7.65% | |||
| EPS Diluted | -37.46% | 7.66% | |||
| Normalized Diluted EPS | -37.36% | 7.65% | |||
| Average Basic Shares Outstanding | 0.38% | 1.43% | |||
| Average Diluted Shares Outstanding | 0.38% | 1.43% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||